Angioedema, ACE inhibitor and COVID-19

SARS-CoV-2, the virus responsible for COVID-19, binds to the ACE2 receptors. ACE2 is thought to counterbalance ACE in the renin-angiotensin system. While presently it is advised that patients should continue to use ACE inhibitors or angiotensin receptor blockers, questions still remain as to whether...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Case Rep
Autori principali: Grewal, Ekjot, Sutarjono, Bayu, Mohammed, Ibbad
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482445/
https://ncbi.nlm.nih.gov/pubmed/32912894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-237888
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi